药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Difenoxin
Bleselumab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Bleselumab.
Difenoxin
Nemolizumab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Nemolizumab.
Difenoxin
Mitazalimab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Mitazalimab.
Difenoxin
Suvratoxumab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Suvratoxumab.
Difenoxin
Asunercept
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Asunercept.
Difenoxin
Ponezumab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Ponezumab.
Difenoxin
Zolbetuximab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Zolbetuximab.
Difenoxin
Utomilumab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Utomilumab.
Difenoxin
Telisotuzumab vedotin
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Telisotuzumab vedotin.
Difenoxin
Tigatuzumab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Tigatuzumab.
Difenoxin
Tezepelumab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Tezepelumab.
Difenoxin
Frovocimab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Frovocimab.
Difenoxin
Abrilumab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Abrilumab.
Difenoxin
Ipafricept
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Ipafricept.
Difenoxin
Tafasitamab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Tafasitamab.
Difenoxin
Apomab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Apomab.
Difenoxin
Gremubamab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Gremubamab.
Difenoxin
Pateclizumab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Pateclizumab.
Difenoxin
Dalantercept
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Dalantercept.
Difenoxin
Margetuximab
The risk or severity of adverse effects can be increased when Polatuzumab vedotin is combined with Margetuximab.